Cite Filings / APRE / 0001104659-20-064979

Feed Companies Filings Check

Sign in

SC 13D/A

Beneficial Ownership Report

Aprea Therapeutics, Inc. Filed 2020-05-22 Acc 0001104659-20-064979

Documents 1

SC 13D/A Beneficial Ownership Report , a20-20667_1sc13da.htm

Around this filing

2020-06-16 SC 13D/A Beneficial Ownership Report
2020-05-22 SC 13D/A Beneficial Ownership Report
2020-05-21 4 Director sold 255,000 shares at $35.15 ($8,963,250)
2020-05-21 4 10% owner sold 255,000 shares at $35.15 ($8,963,250)
2020-05-20 4 10% owner disposed of 3,418,692 shares (other)
2020-05-20 4 10% owner disposed of 120,148 shares (other)
2020-05-15 10-Q Quarterly Report

Link to a passage

Paste a passage to link it

At least 12 characters, not counting spaces, so the link points to one passage.

External

SEC EDGAR (opens in new tab)

Loading a20-20667_1sc13da.htm…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…